Polymorphus Adenocarcinoma (PAC) Polymorphous adenocarcinoma (PAC) accounts for around 12% of malignant salivary gland tumours
Myoepithelial Carcinoma (MC) Myoepithelial carcinoma makes up less than 2% of all salivary gland tumours
Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer Whole-Genome Sequencing (WGS) can be achieved in a clinically relevant timeframe for patients with relapsed/metastatic SGC
Mucoepidermoid Carcinoma (MEC) & Warthin-like MEC Mucoepidermoid Carcinoma (MEC) including Warthin-like MEC
Salivary Gland Cancer Day - 4th October 19 Dec 2025 Raising Awareness for a Rare Disease. Welcome to the WORLD'S FIRST Salivary Gland Cancer Day, being held annually on the 4th of October.
SGC Travel Grants Apply for funding to travel to a conference or workshop. We welcome all applications that are aligned with our strategy.
UK Salivary Gland Cancer Research Working Group (UKSGCWG) 09 Dec 2025 This working group is to identify the gaps in Salivary Gland Cancer Research, develop strategic priorities for this area of research and deliver them.
Basal Cell Adenocarcinoma (BCAC) Basal Cell Adenocarcinoma (BCAC) accounts for 1-3% of salivary gland cancers